Screener
Recursion Pharmaceuticals, Inc. RXRX Prepaid & Other Current
Prepaid & Other Current at other companies
Other financials
Where this comes from
Reported directly by Recursion Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PrepaidExpenseCurrent.
The source filing: Recursion Pharmaceuticals, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 6:32 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001601830-26-000098
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Cash and cash equivalents | $545,683 | $743,294 |
| Restricted cash | 5,385 | 4,594 |
| Other receivables | 14,393 | 24,649 |
| Prepaid data assets | 8,680 | 11,742 |
| Other current assets | 29,321 | 28,566 |
| Total current assets | 603,462 | 812,845 |
| Restricted cash, non-current | 5,752 | 6,033 |
| Property and equipment, net | 89,623 | 103,931 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Recursion Pharmaceuticals, Inc.'s prepaid & other current?
- Recursion Pharmaceuticals, Inc. (RXRX) reported prepaid & other current of $8.68M in Q2 2026.
- What is the long-term trend for Recursion Pharmaceuticals, Inc.'s prepaid & other current?
- Over 5 years (2020 to 2025), Recursion Pharmaceuticals, Inc.'s prepaid & other current has grown at a 40.4% compound annual growth rate (CAGR), from $2.16M to $11.74M.
- What does prepaid & other current mean?
- Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.
Ask your AI about Recursion Pharmaceuticals, Inc.'s prepaid & other current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude